David Zarling

David A. Zarling is a co-founder, president and CEO of Colby Pharmaceutical Company and an oncology drug development scientist and entrepreneur. Zarling also has been a part of teams that successfully licensed technology to start-up companies, one of which subsequently achieved significant market capitalization. Provided by Wikipedia
Showing 1 - 1 results of 1 for search 'David Zarling', query time: 0.02s Refine Results
  1. 1
    Thermophilic Filamentous Fungus C1-Cell-Cloned SARS-CoV-2-Spike-RBD-Subunit-Vaccine Adjuvanted with Aldydrogel<sup>®</sup>85 Protects K18-hACE2 Mice against Lethal Virus Challenge

    Thermophilic Filamentous Fungus C1-Cell-Cloned SARS-CoV-2-Spike-RBD-Subunit-Vaccine Adjuvanted with Aldydrogel<sup>®</sup>85 Protects K18-hACE2 Mice against Lethal Virus Challenge by Ram Nechooshtan, Sharon Ehrlich, Marika Vitikainen, Arik Makovitzki, Eyal Dor, Hadar Marcus, Idan Hefetz, Shani Pitel, Marilyn Wiebe, Anne Huuskonen, Lilach Cherry, Edith Lupu, Yehuda Sapir, Tzvi Holtzman, Moshe Aftalion, David Gur, Hadas Tamir, Yfat Yahalom-Ronen, Yuval Ramot, Noam Kronfeld, David Zarling, Anne Vallerga, Ronen Tchelet, Abraham Nyska, Markku Saloheimo, Mark Emalfarb, Yakir Ophir

    Published 2022-12-01
    Get full text
    Article

Search Tools: